Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density.
Paul Dennis MillerSteven TroyRichard J WeissMiriam AnnettJason SchenseSetareh A WilliamsBruce H MitlakPublished in: Clinical drug investigation (2021)
NCT04366726, Date of registration 04/29/2020, retrospectively registered.